Smith Karen L.

Director at AUPH; Director at ACCELERON PHARMA INC

Sold, on record
$2.9M
Dollars the filings state
Form 4 sales
3
Latest Nov 11, 2024
Form 144 notices
0
Proposed sales
Companies
2
Filed as an executive or holder

Companies

Sales by reason

0
Routine
0
Plan not stated
0
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Sales by company

Shares sold, every Form 4 sale on record.

Timeline

  1. 1 Form 4 sale ACCELERON PHARMA INCUnusual
    Apr 1 2021

    Sold 8,925 shares at $136.47 ($1.2M)

    Smith Karen L., Director

    Sold 66.2% of holdings ($1.8M position)4,561 shares leftFirst sale on recordFiling

  2. 2 Form 4 sale ACCELERON PHARMA INCUnusual
    Apr 5 +4 days

    Sold 11,864 shares at $140.19 ($1.7M)

    Smith Karen L., Director

    Sold 88% of holdings ($1.9M position)1,622 shares leftFiling

  3. 3 Form 4 sale AUPHUnusual
    Nov 11 +1316 days

    Sold 5,241 shares at $8.43 ($44k)

    Smith Karen L., Director

    No 10b5-1 planSold 29.3% of holdings ($151k position)12,672 shares leftFirst sale on recordFiling

Every transaction

Loading transactions…

Sales and notices (3)

Form 144 notices and Form 4 sales by Smith Karen L.
Source
Nov 11, 2024AUPHDirectorForm 4 sale5,241$44k29.3%UnusualSEC
Apr 5, 2021ACCELERON PHARMA INCDirectorForm 4 sale11,864$1.7M88.0%UnusualSEC
Apr 1, 2021ACCELERON PHARMA INCDirectorForm 4 sale8,925$1.2M66.2%UnusualSEC